Predictive biomarkers for ovarian cancer
First Claim
Patent Images
1. An article of manufacture comprising a set of reagents to measure the levels of a panel of biomarkers in a specimen, wherein the panel of biomarkers comprise CA125, Apo A1, HE4, and FSH, and their measurable fragments, and wherein the set of reagents are bound to a solid support and specifically bind to said biomarkers.
3 Assignments
0 Petitions
Accused Products
Abstract
Methods are provided for predicting the presence, subtype and stage of ovarian cancer, as well as for assessing the therapeutic efficacy of a cancer treatment and determining whether a subject potentially is developing cancer. Associated test kits, computer and analytical systems as well as software and diagnostic models are also provided.
81 Citations
18 Claims
- 1. An article of manufacture comprising a set of reagents to measure the levels of a panel of biomarkers in a specimen, wherein the panel of biomarkers comprise CA125, Apo A1, HE4, and FSH, and their measurable fragments, and wherein the set of reagents are bound to a solid support and specifically bind to said biomarkers.
Specification